• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Drudgereport

Latest news from around the world

  • Submit
  • Disclaimers
  • About
  • DMCA
  • Privacy Policy
  • Contact
You are here: Home / Covovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India

Covovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India

Home Health Wellness Wellness on December 29, 2021 The World Health Organization (WHO) has issued a second Emergency Use Listing (EUL) for Novavax NVX-CoV2373, the COVID-19 vaccine developed by American pharma giant Novavax Inc. NVX-CoV2373 is listed as Nuvaxovid and is the 10th COVID-19 vaccine to have been issued an EUL by The Technical Advisory Group for Emergency Use Listing [1] . Nuvaxovid was earlier given a conditional marketing authorisation in the European Union by The European Medicines Agency (EMA). NVX-CoV2373 is also being manufactured and marketed in India and licensed territories by Serum Institute of India Pvt. Ltd. (SII), as Covovax, which was granted EUL on December 17 [2] . “Covovax was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India. The Technical Advisory Group for Emergency Use Listing (TAG-EUL), convened by WHO and made up of experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19, that the benefit of the vaccine far outweighs any risks, and that the vaccine can be used globally,… Read full this story

  • India 'is space power' after missile test
  • Curtain Rises on Dance of Democracy in India: 1st Phase Polling Begins
  • Howzat! Imran Khan Shows His Class in India-Pakistan Showdown
  • Halloween Brexit; polls open in India
  • 19 People to watch in 2019: Christina Verchere (OMV Petrom): Investors need stability and predictability
  • Four things you need to know about Matcha
  • Warring sides blocked vaccine deliveries in Yemen as cholera outbreak worsened: report
  • Vaccine linked to huge cervical disease drop
  • Brexit and holidays: What do I need to know?
  • Clean air charge approved for city
Covovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India have 279 words, post on www.boldsky.com at December 29, 2021. This is cached page on Drudgereport. If you want remove this page, please contact us.

Primary Sidebar

RSS Drudgereport

  • No more tragedies like this
  • Korea’s money supply grows for third straight month
  • Hyundai Motor to recall over 70,000 vehicles over faulty parts
  • Discount shopping coupons offered by government, stockpiles released
  • Emart swings to loss in Q2 on increased expenses, tax

Sponsored Links

  • District CPI(M) to tighten monitoring of members
  • The Speaker who stifled debate
  • Asian Champions Trophy | Dilpreet ’tricks as India wins big
  • AP source: Biden, Manchin sharply divided over $2T Dem bill
  • Biden picks Caroline Kennedy, Michelle Kwan for ambassadors
  • Indonesia’s 2021 human rights record ‘alarming’: Amnesty
  • No move to include Tulu in Eighth Schedule: Centre
  • VHP urges State Govt. to ban Popular Front of India after attack on police
  • Akshaya Patra Foundation to start noon-meal scheme in Jan.
  • In Kerala, the IUML is at a disadvantage
Copyright © 2022 Drudgereport. Power by Wordpress.
Home - About Us - Contact Us - Disclaimers - DMCA - Privacy Policy - Submit your story